(NASDAQ: IVVD) Invivyd's forecast annual revenue growth rate of 95.9% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Invivyd's revenue in 2025 is $36,688,000.On average, 2 Wall Street analysts forecast IVVD's revenue for 2025 to be $8,943,125,725, with the lowest IVVD revenue forecast at $7,233,675,134, and the highest IVVD revenue forecast at $10,652,576,316. On average, 2 Wall Street analysts forecast IVVD's revenue for 2026 to be $20,327,466,855, with the lowest IVVD revenue forecast at $15,463,030,261, and the highest IVVD revenue forecast at $25,191,903,450.
In 2027, IVVD is forecast to generate $33,637,189,178 in revenue, with the lowest revenue forecast at $33,637,189,178 and the highest revenue forecast at $33,637,189,178.